Screener
PTC Therapeutics PTCT Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Change in valuation of contingent consideration | — | (800) |
| Tangible asset impairment and losses on transactions, net | 927 | 77 |
| Unrealized loss on ClearPoint Equity Investments | — | 3,122 |
| Unrealized gain on marketable securities - equity investments | (1,214) | (774) |
| Deferred income taxes | (10) | 2 |
| Amortization of discounts on investments, net | (4,114) | (2,313) |
| Amortization of debt issuance costs | 305 | 299 |
| Share-based compensation expense | 23,421 | 18,060 |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's net gains (losses) on investments?
- PTC Therapeutics (PTCT) reported net gains (losses) on investments of $1.21M in Q1 2026.
- How has PTC Therapeutics's net gains (losses) on investments changed year-over-year?
- PTC Therapeutics's net gains (losses) on investments increased by 56.8% year-over-year, from $774K to $1.21M.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.
Ask your AI about PTC Therapeutics's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude